“Complement Inhibition in Rare Kidney Disease: Response Heterogeneity and Biomarker-Guided Withdrawal” (2025) Translational Medicine & Therapeutics Journal, 4(1), pp. 28–36. doi:10.5281/zenodo.22649336.